• No results found

Reporting of harm in randomized controlled trials evaluating stents for percutaneous coronary intervention

N/A
N/A
Protected

Academic year: 2020

Share "Reporting of harm in randomized controlled trials evaluating stents for percutaneous coronary intervention"

Copied!
7
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Table 1: Reports characteristics
Table 3: Reporting of harm in reports of randomized controlled trials assessing stent treatment for coronary diseases by type of stent

References

Related documents

Results are presented in form of graphs, representing the average Nusselt number and friction factors, the dimensionless temperature at the outlet section, the local Nusselt number

Leishmania amazonensis –induced CD200 expression requires TLR9, MyD88, and TRIF signaling pathways in macrophages infected with amastigotes.. (A) A TLR9 agonist induces

To quantitatively determine the levels of circulating endotrophin in human plasma collected from breast cancer patients, 96-well maxi-sorp plates (Corning Costar) were coated

Tables  2 and 3 summarize the accuracy of agonist and antagonist activity estimates for the evaluation set chemi- cals obtained by using the kNN models, the GkNN model, and

As for the Beninese Agency for the Valorization of Research Results and Technological Innovation, it is created by decree n ° 2012-139 of June 7, 2012 and